Atlas Venture Life Science Advisors, LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kymera Therapeutics, Inc.(KYMR) | 4,896,462 | 4,896,462 | 0 | 213,681,602 | 277,139,749 | 36.82% | +63,458,147 |
| Sionna Therapeutics, Inc.(SION) | 3,694,020 | 3,615,527 | -78,493 | 64,091,247 | 106,332,649 | 14.13% | +42,241,402 |
| Korro Bio, Inc. | 1,137,149 | 1,137,149 | 0 | 14,202,991 | 54,458,066 | 7.24% | +40,255,075 |
| Dyne Therapeutics, Inc.(DYN) | 9,130,465 | 9,130,465 | 0 | 86,922,027 | 115,500,382 | 15.35% | +28,578,355 |
| Disc Medicine, Inc.(IRON) | 2,384,456 | 2,142,617 | -241,839 | 126,280,790 | 141,584,131 | 18.81% | +15,303,341 |
| Day One Biopharmaceuticals, Inc. | 6,430,257 | 6,430,257 | 0 | 41,796,671 | 45,333,312 | 6.02% | +3,536,641 |
| ImageneBio, Inc. | 0 | 377,814 | +377,814 | 0 | 3,079,184 | 0.41% | +3,079,184 |
| Generation Bio, Co. | 8,279,484 | 827,946 | -7,451,538 | 2,650,263 | 5,067,030 | 0.67% | +2,416,767 |
| Q32 Bio, Inc. | 2,092,106 | 2,092,106 | 0 | 3,117,238 | 4,142,370 | 0.55% | +1,025,132 |
| Ikena Oncology, Inc. | 5,018,178 | 0 | -5,018,178 | 6,724,359 | 0 | — | -6,724,359 |
| Vigil Neuroscience, Inc. | 5,836,874 | 0 | -5,836,874 | 46,403,148 | 0 | — | -46,403,148 |
| Third Harmonic Bio, Inc. | 10,402,286 | 0 | -10,402,286 | 56,484,413 | 0 | — | -56,484,413 |